Hennion & Walsh Asset Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $118K | Sell |
|
|||||
|
2024
Q4 | $99.1K | Sell |
|
|||||
|
2024
Q3 | $285K | Sell |
|
|||||
|
2024
Q2 | $454K | Sell |
|
|||||
|
2024
Q1 | $1.25M | Buy |
|
|||||
|
2023
Q4 | $1.33M | Sell |
|
|||||
|
2023
Q3 | $1.76M | Buy |
|
|||||
|
2023
Q2 | $3.82M | Buy |
|
|||||
|
2023
Q1 | $3.05M | Buy |
|
|||||
|
2022
Q4 | $2.71M | Sell |
|
|||||
|
2022
Q3 | $3.15M | Buy |
|
|||||
|
2022
Q2 | $2.53M | Buy |
|
|||||
|
2022
Q1 | $2.07M | Buy |
|
|||||
|
2021
Q4 | $2.22M | Buy |
|
|||||
|
2021
Q3 | $1.68M | Sell |
|
|||||
|
2021
Q2 | $2.2M | Sell |
|
|||||
|
2021
Q1 | $2.93M | Buy |
|